pharmaceuticals

Latest news and articles about pharmaceuticals from NEX English

Amazon Launches New Weight Loss Pills from Lilly in U.S. Kiosks

Amazon has announced the availability of new weight loss pills developed by Lilly in its kiosks across the United States, with same-day delivery options. This move comes as the American market sees a growing demand for weight loss solutions.

Israeli and American Attacks Damage 25 Pharmaceutical Facilities in Iran

The spokesperson for the Iranian Pharmacists Union reported that Israeli and American attacks have caused significant damage to 25 pharmaceutical facilities in Iran, raising concerns about the impact on the country's healthcare sector. This comes amid escalating tensions between Iran and the United States and its allies in the region.

Trump imposes new tariffs on pharmaceuticals and metals

On Thursday, U.S. President Donald Trump announced new tariffs on certain pharmaceuticals and a restructuring of tariffs on metals. This move reflects his ongoing trade policy aimed at protecting American industry.

EPA classifies microplastics and pharmaceuticals as water pollutants

The U.S. Environmental Protection Agency (EPA) announced plans to classify microplastics and pharmaceuticals as contaminants in drinking water, reflecting growing concerns about water quality and human health. This decision comes amid increasing global awareness of pollution risks.

Bayer announces strategic shift towards the American market

German pharmaceutical giant Bayer has announced that it expects to generate most of its revenue from the American market following a strategic shift in its business model. This change comes as Europe faces challenges in providing affordable medications.

Secure funding for pharmaceuticals in Tunisia after president's visit

In a significant move, Tunisian President Kais Saied has authorized financial allocations for the Central Pharmacy, aiming to ensure a continuous supply of medications in the market. This decision comes as patients face a severe shortage of essential drugs.

Mercedes acquires Turns Pharmaceuticals for $6.7 billion

Mercedes has announced its acquisition of Turns Pharmaceuticals for <strong>$6.7 billion</strong>, granting access to a promising treatment for <strong>blood cancer</strong>. This move comes as the company faces the expiration of a patent for one of its best-selling cancer drugs.